Skip to main content
Premium Trial:

Request an Annual Quote

Cancer Detection Firm Micronoma Raises $3.5M

NEW YORK ─ Cancer detection firm Micronoma on Wednesday announced the closing of $3.5 million in convertible debt financing.

The San Diego-based developer of microbiome-based cancer detection technology said that the additional financing will enable it to complete a validation study on lung cancer prediction, set up CLIA operations, establish its go-to-market strategy utilizing its Oncobiota platform, and initiate work on a second cancer target.

Existing US-based investor SymBiosis and a new European-based investor Seerave Foundation contributed to the financing. 

Following the closing of a $3 million seed round last August, the new financing round brings the total amount of funding for Micronoma to $6.5 million.

Micronoma was spun out of the University of California, San Diego in 2019 to commercialize liquid biopsy technology based on the discovery that unique microbial DNA signatures in blood and tissue could distinguish healthy individuals from patients with a variety of cancers.

The Scan

Billion-Dollar Diversity Initiative

The Howard Hughes Medical Institute is now accepting applications for its new $1.5 billion initiative to boost the diversity of the scientific workforce.

Biotech Co-Founder Arrested

A co-founder of a Los Angeles-based biotech company has been arrested in connection with a murder-for-hire scheme, according to Endpoint News.

Return of the Tasmanian Tiger

The Washington Post reports that a team in Australia is working to bring the thylacine back from extinction.

Nature Papers on Genome of Individual From Pompeii, CircRNA Study Best Practices, More

In Nature this week: first sequenced genome of a person from Pompeii, best practice guidelines for circRNA studies, and more.